ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,683.65
-0.33%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
152.97
-0.06%
Brent Oil
82.765
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Myriad Genetics Inc (MYGN)

  7. Myriad Genetics Inc (MYGN) ニュース

MYGN Myriad Genetics Inc

19.43
0.21 (1.09%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Myriad Genetics Inc MYGN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.21 1.09% 19.43 06:58:41
始値 安値 高値 終値 前日終値
19.85 19.40 20.09 19.47 19.22
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0105:05GLOBEMyriad Genetics to Release First Quarter 2024 Financial..
2024/4/1721:00GLOBENearly Half of Americans Say They’ve Lost Time in Their..
2024/4/1622:15GLOBENew Myriad Genetics Study Published in Prenatal Diagnosis..
2024/4/0921:00GLOBEMyriad Genetics Research Shows Reduction in Hospitalizations..
2024/3/2210:40GLOBEMyriad Genetics Announces Foundational Patent Granted for..
2024/3/2105:05GLOBEMyriad Genetics Announces Patent Granted for SneakPeek® Snap..
2024/3/0506:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2822:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2806:05EDGAR2Form 8-K - Current report
2024/2/2806:05GLOBEMyriad Genetics Reports Strong Fourth Quarter and Full-Year..
2024/2/2723:15GLOBEMyriad Genetics and National Cancer Center Hospital East in..
2024/2/2706:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2706:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2206:05GLOBEMyriad Genetics to Release Fourth Quarter and Full Year 2023..
2024/2/1606:05GLOBEMyriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as..
2024/2/1506:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1422:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0900:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0123:25GLOBEMyriad Genetics Completes Acquisition of Precise Tumor,..
2024/2/0106:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3107:00GLOBEMyriad Genetics Names George Daneker Jr., MD, as President..
2024/1/3006:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3006:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/2406:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2304:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/1908:10GLOBEMyriad Genetics to Acquire Precise Tumor, Precise Liquid and..
2024/1/1623:00EDGAR2Form 8-K - Current report
2024/1/1006:05GLOBEMyriad Genetics Applauds New Germline Testing Guideline for..
2024/1/0406:05GLOBEMyriad Genetics to Present at 42nd Annual J.P. Morgan..
2024/1/0307:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2122:30EDGAR2Form 8-K - Current report
2023/12/2122:30GLOBEMyriad Genetics Chief Financial Officer Bryan Riggsbee..
2023/12/2022:00GLOBEMyriad Genetics Establishes Comprehensive Pan-Cancer..
2023/12/1208:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1208:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/12/0606:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2106:05GLOBEMyriad Genetics Celebrates One Million SneakPeek® Results..
2023/11/1706:05GLOBEMyriad Genetics and Personalis Partner to Market..
2023/11/1406:31EDGAR2Form 8-K - Current report
2023/11/1320:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/0921:00GLOBEMyriad Genetics to Participate in Stephens Annual Investment..
2023/11/0911:20GLOBEMyriad Genetics Announces Pricing of Upsized Offering of..
2023/11/0911:16EDGAR2Form 8-K - Current report
2023/11/0906:10GLOBEMyriad Genetics Announces Proposed Offering of $100 Million..
2023/11/0906:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/0906:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2023/11/0722:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0706:05EDGAR2Form 8-K - Current report
2023/11/0706:05GLOBEMyriad Genetics Reports Third Quarter 2023 Financial..
2023/11/0406:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

NASDAQ
MYGN
Myriad Genetics
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有